GlassScriptPhysician profile
Nicholas Tinkham
NPI 1871810721
$6,002.86
in general payments reported to CMS, 2019-2025
11 companies · $944 in 2025
The $944 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $612 · 2021: $926 · 2022: $722 · 2023: $2,203 · 2024: $180 · 2025: $944.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,304 · Travel and Lodging: $1,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,303.65 |
| Travel and Lodging | $1,023.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,482.84 | 2021-2025 | Intellis Adaptivestim |
| Boston Scientific Corporation | $1,404.81 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Relievant Medsystems, INC. | $1,321.52 | 2023 | Intracept |
| Medtronic USA, INC. | $645.06 | 2019-2020 | |
| Saluda Medical Americas, INC. | $392.77 | 2025 | Evoke |
| Abbott Laboratories | $229.30 | 2023-2024 | Proclaim |
| Mml US, INC. | $135.56 | 2023 | Reactiv8 |
| Si-Bone, INC. | $133.94 | 2023 | |
| Spr Therapeutics, INC | $119.57 | 2023 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $115.63 | 2025 | |
| Painteq LLC | $21.86 | 2023 | Painteq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Tinkham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.